Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study.

Matteo GastaldiThomas FoiadelliGiacomo GrecoSilvia ScaranzinEleonora RigoniStefano MasciocchiSergio FerrariChiara Rosa MancinelliLaura BrambillaMargherita MancardiThea GiacominiDiana FerraroMarida Della CorteAntonio GalloMassimiliano Di FilippoLuana BenedettiGiovanni NoviMaurizio VersinoPaola BanfiRaffaele IorioLucia MoiolaEmanuela TurcoStefano SartoriMargherita NosadiniMartino RuggieriSalvatore SavastaElena ColomboElena BallanteSven JariusSara MariottoDiego Franciottanull null

Published in: Journal of neurology, neurosurgery, and psychiatry (2022)

Persistent MOG-IgG positivity and high remission titres are associated with an increased relapse risk. Longitudinal MOG-IgG titres could be useful to stratify patients to be treated with long term immunosuppression.

Keyphrases

end stage renal disease
newly diagnosed
cross sectional
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
study protocol
randomized controlled trial
systemic lupus erythematosus
free survival
double blind
patient reported